Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23890405 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A
Condition: Influenza
Interventions: Biological: GlaxoSmithKline Biologicals' influenza vaccine GSK576389A;   Biological: Fluarix

Indicates status has not been verified in more than two years